(Q40392363)

20 September 2017

1 reference

title

Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal (English)

1 reference

20 September 2017

0 references

J C Hurley

1

1 reference

20 September 2017

publication date

1 June 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

47

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

855-861

1 reference

Gram-negative sepsis: what dilemma?

20 September 2017

cites work

1 reference

12 December 2020

Septic shock: pathogenesis

1 reference

12 December 2020

Anti-endotoxin monoclonal antibodies

1 reference

12 December 2020

Reappraisal of the role of endotoxin in the sepsis syndrome

1 reference

12 December 2020

Effect of methylprednisolone on bacterial clearance and endotoxin liberation during experimental sepsis induced by gram-negative bacteria

1 reference

12 December 2020

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group

1 reference

12 December 2020

Resistance to meningococcemia apparently conferred by anti-H.8 monoclonal antibody is due to contaminating endotoxin and not to specific immunoprotection

1 reference

12 December 2020

Predictors of bacteremia and gram-negative bacteremia in patients with sepsis. The Veterans Affairs Systemic Sepsis Cooperative Study Group

1 reference

12 December 2020

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

12 December 2020

Protective antibody to endotoxin core: the emperor's new clothes?

1 reference

12 December 2020

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels

1 reference

12 December 2020

Clinical effects and therapy of endotoxaemia

1 reference

12 December 2020

Septic shock: treatment

1 reference

12 December 2020

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

1 reference

12 December 2020

Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide.

1 reference

12 December 2020

Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.

1 reference

12 December 2020

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

12 December 2020

Therapeutic trial of lipid X in a canine model of septic shock

1 reference

12 December 2020

Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia

1 reference

12 December 2020

Antibiotic-induced release of endotoxin: a reappraisal

1 reference

12 December 2020

A controlled trial of HA-1A in a canine model of gram-negative septic shock.

1 reference

12 December 2020

Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital

1 reference

12 December 2020

Gram-negative rod bacteremia.

1 reference

12 December 2020

Early treatment with parenteral penicillin in meningococcal disease

1 reference

12 December 2020

Endotoxemia in human septic shock

1 reference

12 December 2020

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

1 reference

12 December 2020

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

12 December 2020

Choice of bacteria in animal models of sepsis.

1 reference

12 December 2020

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

12 December 2020

Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies

1 reference

12 December 2020

Additional evidence that the Lps gene locus regulates natural resistance to S. typhimurium in mice.

1 reference

12 December 2020

The efficacy of combination immunotherapy in experimental Pseudomonas sepsis

1 reference

12 December 2020

Immunolabeling of lipopolysaccharide liberated from antibiotic-treated Escherichia coli.

1 reference

12 December 2020

Implications of endotoxin contamination in the evaluation of antibodies to lipopolysaccharides in a murine model of gram-negative sepsis.

1 reference

12 December 2020

Bacteremia, endotoxemia, and mortality in gram-negative sepsis: a reappraisal

1 reference

12 December 2020

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

1 reference

12 December 2020

Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose Dexamethasone

1 reference

12 December 2020

Comparison of gentamicin and polymyxin B-kanamycin in therapy of bacteremia due to gram-negative bacilli

1 reference

12 December 2020

Endotoxaemia or endotoxinaemia?

1 reference

12 December 2020

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

10.2165/00003495-199447060-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1014926323

0 references

1 reference